Harold Bays
Impact in
- Endocrinology, Diabetes and Metabolism top 0.05%
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Diabetes Treatment and Management
- Surgery top 0.05%
- Lipoproteins and Cardiovascular Health
Papers in
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 101
- Diabetes Treatment and Management 51
- Surgery 205
- Lipoproteins and Cardiovascular Health 175
- Co-authors
- Christie M. BallantyneMichael H. DavidsonPeter H. JonesJames M. McKenneyEvan A. SteinKevin C. MakiCarlos A. DujovneLawrence J. Mandarino
- Journals
- Journal of clinical lipidology (53 papers)The American Journal of Cardiology (33 papers)Journal of the American College of Cardiology (18 papers)International Journal of Clinical Practice (11 papers)Atherosclerosis (10 papers)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Harold Bays
342 papers receiving 18.1k citations
Hit Papers
Peers
Comparison fields: 5 of 161
- Endocrinology, Diabetes and Metabolism 7.2k
- Surgery 10.0k
- Cardiology and Cardiovascular Medicine 3.4k
- Cancer Research 2.2k
- Pharmacology 2.4k
Countries citing papers authored by Harold Bays
This map shows the geographic impact of Harold Bays's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harold Bays with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harold Bays more than expected).
Fields of papers citing papers by Harold Bays
This network shows the impact of papers produced by Harold Bays. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harold Bays. The network helps show where Harold Bays may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Harold Bays, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 14 | |
| 4 | 2024 | 5 | |
| 5 | 2023 | 66 | |
| 6 | 2023 | 27 | |
| 7 | 2022 | 41 | |
| 8 | 2022 | 10 | |
| 9 | 2021 | 1 | |
| 10 | 2021 | 97 | |
| 11 | 2020 | 32 | |
| 12 | Abstract 11417: Bempedoic Acid and Glycemic Control: A Pooled Analysis of 4 Phase 3 Clinical Trials | 2019 | 2 |
| 13 | 2017 | 90 | |
| 14 | Abstract 15071: AMR101 Lowers Triglycerides, Atherogenic Lipoprotein, Phospholipase A2, and High-sensitivity C-reactive Protein Levels in Patients With High Triglycerides and on Background Statin Therapy (the ANCHOR Study) | 2011 | 3 |
| 15 | 2010 | 7 | |
| 16 | 2008 | 196 | |
| 17 | 2008 | 118 | |
| 18 | Colesevelam hydrochloride: reducing atherosclerotic coronary heart disease risk factors | 2007 | 3 |
| 19 | Metabolic syndrome: what might be occurring? | 2004 | 2 |
| 20 | 2003 | 135 |
About Harold Bays
Harold Bays is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery, Pharmacology, Pharmacy and Cardiology and Cardiovascular Medicine, having authored 356 papers that have together received 19.0k indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (175 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (101 papers), Pharmacology and Obesity Treatment (65 papers), Diet and metabolism studies (52 papers), Diabetes Treatment and Management (51 papers), Pharmaceutical Economics and Policy (39 papers), Cancer, Lipids, and Metabolism (37 papers) and Health Systems, Economic Evaluations, Quality of Life (36 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (7.2k citations), Surgery (10.0k citations), Cardiology and Cardiovascular Medicine (3.4k citations), Cancer Research (2.2k citations) and Pharmacology (2.4k citations). Harold Bays has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Christie M. Ballantyne, Michael H. Davidson, Peter H. Jones, James M. McKenney, Evan A. Stein, Kevin C. Maki, Carlos A. Dujovne, Lawrence J. Mandarino, Ralph A. DeFronzo and Terry A. Jacobson. Their work appears in journals such as Journal of clinical lipidology, The American Journal of Cardiology, Journal of the American College of Cardiology, International Journal of Clinical Practice and Atherosclerosis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.